Navigation Links
Westaim announces 2007 year-end results
Date:2/15/2008

hs Twelve Months

Ended December 31 Ended December 31

--------------------- ---------------------

(thousands of dollars except

per share data) 2007 2006 2007 2006

-------------------------------------------------------------------------

Revenue $ 11,174 $ 5,140 $ 31,830 $ 27,591

Costs

Manufacturing 3,226 2,899 14,617 17,324

Research and development 1,334 1,966 6,356 12,112

General and administrative 2,660 2,101 9,348 6,762

Depreciation and amortization 403 635 2,093 2,614

Corporate costs 1,845 1,050 10,856 6,123

-------------------------------------------------------------------------

Operating income (loss) 1,706 (3,511) (11,440) (17,344)

Foreign exchange (loss)

gain (305) 1,331 (3,804) (720)

Interest 141 653 1,822 3,242

Change in fair value of

third party asset-backed

commercial paper (1,067) - (4,048) -

Loss on sale of third

party asset-backed

commercial paper (1,067) - (1,067) -

Write-down of capital

assets and intangible

assets - (1,210) (1,203) (1,210)

Gain on sale of capital

assets 75 - 8,722 -

Dilution gain - - 4,525 -

Gain on sale of investment 2,648 - 2,648 -

Loss on issuance of shares

of subsidiary (14) (5
'/>"/>

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
2. Westaim reduces ABCP exposure
3. Westaim announces 2007 third quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
5. The Westaim Corporation update on status of short-term investments
6. Abbott Announces 10.8 Percent Increase in Quarterly Dividend
7. China Holdings Announces Starwood Research Institute Initiates Research Coverage
8. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
9. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
10. Nerites Corporation Announces Closing of Series A Funding Round
11. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2Who Says Negatives Cant Be Positive 3F 50764 1Who Says Negatives Cant Be Positive 3F 50764 2Who Says Negatives Cant Be Positive 3F 50764 3Moles and melanoma researchers find genetic links to skin cancer 50761 1Moles and melanoma researchers find genetic links to skin cancer 50761 2New national genome center launched 9110 1New national genome center launched 9110 2New national genome center launched 9110 3